[
    [
        {
            "time": "2023-10-05",
            "original_text": "New empagliflozin data shows statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction",
            "features": {
                "keywords": [
                    "empagliflozin",
                    "statistically significant",
                    "heart failure",
                    "improvement",
                    "preserved ejection fraction"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "New empagliflozin data shows statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Cassava (SAVA) Down as Quanterix Issues Statement on AD Study",
            "features": {
                "keywords": [
                    "Cassava",
                    "SAVA",
                    "Down",
                    "Quanterix",
                    "Statement",
                    "AD Study"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Cassava (SAVA) Down as Quanterix Issues Statement on AD Study",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]